Argus upgrades Teva to Buy, sees stock ‘attractively priced’
PremiumThe FlyArgus upgrades Teva to Buy, sees stock ‘attractively priced’
15d ago
Teva upgraded to Buy from Hold at Argus
PremiumThe Fly
Teva upgraded to Buy from Hold at Argus
15d ago
Teva price target raised to $24 from $22 at UBS
PremiumThe Fly
Teva price target raised to $24 from $22 at UBS
15d ago
Teva’s agreement with the ITA has no impact on 2024 financial outlook
PremiumThe FlyTeva’s agreement with the ITA has no impact on 2024 financial outlook
1M ago
Teva reaches agreement with ITA, will pay $750M between 2024-2029
PremiumThe Fly
Teva reaches agreement with ITA, will pay $750M between 2024-2029
1M ago
Teva announces launch of authorized generic of Victoza in the U.S.
PremiumThe Fly
Teva announces launch of authorized generic of Victoza in the U.S.
1M ago
Teva presents first real-world data from IMPACT-TD Registry study
PremiumThe FlyTeva presents first real-world data from IMPACT-TD Registry study
2M ago
Teva price target raised to $21 from $18 at BofA
PremiumThe Fly
Teva price target raised to $21 from $18 at BofA
2M ago
Teva says FDA approves AUSTEDO XR as one pill, once-daily
PremiumThe Fly
Teva says FDA approves AUSTEDO XR as one pill, once-daily
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100